@Andy, is there a recording available?
What was the rationale for inviting Amy Proal (viral persistence) and Manoj Sivan (all healthcare is rehab
https://www.s4me.info/threads/an-op...uide-to-therapy-2025.48904/page-4#post-675448)?
From AfME's website (which I don't think has a recording for the PRIME Workshop 1 held in January yet), the aim of PRIME is:
... to bring together researchers from a range of backgrounds, and private sector/industry partners to investigate the genetics, biomarkers and disease mechanisms of ME/CFS and to identify a pathway towards effective treatments.
PRIME stands for “Building Infrastructure for Patients, Researchers and Industry for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.”
It is an initiative designed to strengthen and accelerate research into ME/CFS. Funded by the UK Medical Research Council from 2025–2029, PRIME is led by the University of Edinburgh in partnership with Action for ME and aims to:
· Catalyse 15 new research collaborations
· Develop two international research consortia
· Establish a Public and Patient Involvement Pool to support meaningful collaboration with people with lived experience in research
Building research infrastructure is a laudable aim, but I feel a bit uneasy that PRIME may be reaching out to a whole lot of people who probably should not be platformed. I hope it will not be a tick box exercise of 'catalysing 15 new research collaborations' with researchers close to hand, already in the ME/CFS and LC spaces, eager for any platform and possibly doing work that is counterproductive. The aim of 15 research collaborations is all very good, but if they are going to just be the same people saying the same things, it won't get us very far. For example, from what
@Jonathan Edwards says about Manoj Sivan's presentation and what we know about him already, it will be a shame if he is part of any PRIME collaborations and planned international research consortia.
Manoj Sivan talked about diagnostic criteria and PROMS for reasons that I was not clear. He claims that you do not need a controlled trial to tell if your treatment strategy works - just a consensus.
I listened to this.
Nothing very new I am afraid.
With a workshop topic that seemed to fundamentally misunderstand the nature of the Long COVID label, seeing Long Covid as a single disease (see
my post on that upthread) and some odd choices of presenters, things are looking a little concerning. It's early days of course. I really hope that scarce funding will not be frittered away on more of the usual people saying the usual things. As a person with ME/CFS wanting answers, I value quality over quantity.